In 1997, the year that the Emory CFAR was first organized with institutional funding, physicians and scientists at Emory who were committed to AIDS research were isolated in pockets of scientific excellence scattered throughout the campus. Over the next several years, CFAR worked to facilitate increased integration of HIV /AIDS research on campus, encourage widespread recognition of the importance of interdisciplinary research, assist in the strategic recruitment of needed junior and senior faculty to fill critical gaps in Emory's growing HIV/AIDS research program, and help Emory faculty members get their first NIH funding in HIV/AIDS.
Less than ten years later, AIDS research at Emory has greatly matured. Total HIV/AIDS funding at Emory has increased nearly three-fold from $23 million in 1996 to $59 million in 2005 and the University's AIDS research program now encompasses the full translational pipeline from concept to bench to bedside to community in the domains of vaccines, drug discovery, and behavioral interventions.